as the field experts we have but usamriid a presence in outbreak investigations predates the 1995 kikwit outbreak. again this was a great unique field situation because the concern was a virus may be high up in the canopy. and never looked as hot in the canopy and we partner with other nations in this effort develop catwalks through the canopy and trap and collected blood from species to live high up in the canopy rather than on the forest floor. we brought an element of experience to these and coupled with our interagency and international partners build strong teams both in kikwit where we were -- work in collaboration with the centers for disease control and world health organization. this is a pretty busy slight officials our entire portfolio of areas that we are currently working on, the research and develop an and test and evaluation. but i want to draw your attention to the four bolded bullet obviously. ebola therapeutics, vaccines, and in the joint biological identification system. and the ebola virus diagnostics. vaccines and therapeutics usamriid i think there may be only one o

and in this case we had a product that was really for ebola zaire that was found in kikwit and it turnsout it's different than the one circulating in western africa. so working with our commercial partner in a of i want to say two or three months, they were able to identify the sequence and develop a product that was specific for the virus in west africa. now, there are some ongoing tests of this compound in west africa. not done with us, but done with the european consortia. and, again this highlights once again the relationships that are needed to keep these products under development and keep them moving forward, it's just not dod can, it's not even just u.s. government. in many ways they're international efforts. and the last tier of our three areas to work on is prevention some of the vaccine work. so we began working on ebola vaccines back in 2010. and so that's our group in advanced development. but in the he can tech-based louisiana laboratories, they've been working on it far longer than that. we had a trivail lent vaccine effort going, and that was intended to treat not just e